Findings among sexual and gender minority youth followed for roughly 3.5 years
WEDNESDAY, May 29, 2024 (HealthDay News) — Changes in gender identity are not associated with changes in depressive symptoms over time among sexual and gender minority (SGM) youth, according to a study published online May 22 in JAMA Network Open.
André Gonzales Real, M.D., from The University of Texas at Austin, and colleagues examined whether gender identity trajectories and changes in youth-reported gender identity are associated with depressive symptoms over time. Analysis included 366 SGM youths (aged 15 to 21 years) participating in four waves (every nine months) of a longitudinal U.S. community-based study (November 2011 to June 2015).
The researchers found that one in five (18.3 percent) reported a different gender identity over approximately 3.5 years, with 28 youths varying gender identity more than twice. At baseline, participants with a cisgender to transgender or gender-diverse trajectory reported higher levels of depression versus the group identifying as cisgender at all time points. However, there was no statistical difference once exposure to lesbian, gay, bisexual, and transgender violence was taken into account. Variability in gender identity was not associated with within-person change in depressive symptoms or the level of depressive symptoms.
“In this study, changes in gender identity were not associated with depressive symptoms, suggesting that gender identity exploration is a normal part of adolescent development for some youths,” the authors write.
Characteristics of Individuals Diagnosed With Autism Have Changed Since 2010
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
Better Youth Fitness May Lower Risk for Depression in Adulthood
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
Prep for Conservative Management, Dialysis Yield Similar Results in Older Patients With Kidney Failure
Weight-Loss Surgery Produces Lasting Diabetes Remission
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria